Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs…
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations. The post Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss appeared first on MedCity News.
4 Notable Health Tech Funding Announcements in May
Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in May appeared first on MedCity News.
Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough
Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address. The post Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough appeared first on MedCity News.
Medical Education Is at a Crossroads. AI Isn’t the Problem — It’s the Mirror
The real question is whether we’re being honest with ourselves about what medical education was designed to produce, and whether our current system is still doing that job. The post Medical Education Is at a Crossroads. AI Isn’t the Problem — It’s the Mirror appeared first on MedCity News.
Preparing Benefits For the Next Wave: Gene Therapy Medications
The rise of metabolic gene therapies represents a critical juncture for benefits management. These treatments offer genuine hope for patients with serious conditions, but they also pose significant financial challenges. The post Preparing Benefits For the Next Wave: Gene Therapy Medications appeared first on MedCity News.
Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed recent warnings about research-grade peptides and new colorectal cancer screening guidelines on CBS News’ CBS Mornings on May 27. She also discussed the Ebola outbreak centered on the Democratic Republic of Congo and whether it’s expected to spread on May 26. Click here to watch…
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Abridge, Highmark Health and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health and Novartis. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.
Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing
Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs to source biotech innovation. This alliance will focus on developing next-generation drugs in the class of targeted cancer therapies called antibody drug conjugates. The post Pfizer’s $10.5B Deal With One…
Garner Health Secures $100M to Connect Patients with High-Performing Doctors
Garner’s Series E round was led by Index Ventures with participation from Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund and Kaiser Permanente Ventures. The post Garner Health Secures $100M to Connect Patients with High-Performing Doctors appeared first on MedCity News.
Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
Montana will soon test whether cash-strapped and strained state health departments can carry out federal Medicaid work requirements without ending coverage for eligible adults. On July 1, Montana plans to become the second state after Nebraska to make Medicaid enrollees prove they’re working to keep their coverage. That’s six months ahead of the federal deadline for states to implement Medicaid work rules for…
